Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Neogenomics Inc (NQ: NEO)
18.98 USD  +0.48 (+2.59%)
Official Closing Price  /  Updated: 5:21 PM EST, Feb 22, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 902,900
Open 18.63
Bid (Size) 18.28 (5)
Ask (Size) 19.24 (3)
Prev. Close 18.50
Today's Range 18.36 - 19.07
52wk Range 7.710 - 19.07
Shares Outstanding 80,617,016
Dividend Yield N/A
Performance
YTD
+51.36%
+51.36%
1 Month
+18.33%
+18.33%
3 Month
+18.70%
+18.70%
6 Month
+39.56%
+39.56%
1 Year
+130.06%
+130.06%
Top News
More News
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter and full year 2018. Read More
from GlobeNewswire News Releases
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its fourth quarter and fiscal year 2018 financial results on... Read More
from GlobeNewswire News Releases
More News
Read More
Report: Developing Opportunities within Macerich, Illinois Tool Works, NeoGenomics, Bunge, Dolby Laboratories, and Cracker Barrel Old Country Store — Future Expectations, Projections Moving into 2019
from GlobeNewswire News Releases
NeoGenomics Set to Join S&P SmallCap 600
from PR Newswire
Neogenomics Inc Shares Up 42.2% Since SmarTrend's Buy Recommendation (NEO)
from Comtex SmarTrend® News Briefs
32.1% Return Seen to Date on SmarTrend Neogenomics Inc Call (NEO)
from Comtex SmarTrend® News Briefs
Neogenomics Inc (NEO) Q4 2018 Earnings Conference Call Transcript
category NEO , Market News
from Motley Fool
Jim Cramer Weighs In On CVS Health, NeoGenomics And More
category Jim Cramer , WDFC , VICR , and 10 more.
from Benzinga
Neogenomics Inc Shares Up 29.8% Since SmarTrend's Buy Recommendation (NEO)
from Comtex SmarTrend® News Briefs
Neogenomics Inc Has Returned 28.0% Since SmarTrend Recommendation (NEO)
from Comtex SmarTrend® News Briefs
Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January
category NEO , NVTA , Market News , and 1 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.